Given the spatial distribution of GO nanosheets throughout the tumor volume and their retention within the tumor, we reasoned that complexation of the nanomaterial with a chemotherapeutic drug such as BTZ may improve the localization, persistence, and activity of the drug following direct (intratumoral) administration. This evidence concerns the gene CASC3 and neoplasm.